EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Multicenter, real-world observational study of AVA therapy following ELT/HET switching in Chinese children with persistent/chronic primary ITP

Jingjing Liu, Zhifa Wang, Nan Wang, Jingyao Ma, Lijuan Wang, Yan Liu, Jinxi Meng, Shuyue Dong, Yu Hu, Juntao Ouyang, Zhenping Chen, Xiaoling Cheng und 1 weitere

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06567-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Hematology, 2025. Verfasst von Jingjing Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's …. Hauptthemen laut MEDLINE: Benzoates, Drug Substitution, Hydrazines, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Avatrombopag (AVA), a second-generation thrombopoietin receptor agonist (TPO-RA), has demonstrated efficacy in pediatric persistent/chronic immune thrombocytopenia (ITP). However, critical evidence gaps persist regarding treatment-switching strategies between TPO-RAs, particularly when transitioning from eltrombopag (ELT) or hetrombopag (HET) to AVA. This multicenter cohort study evaluated 55 pediatric ITP patients unresponsive to or relapsing after ELT (n = 46) or HET (n = 9) who underwent AVA switch therapy. Outcomes included platelet response (≥ 30 × 10⁹/L without rescue therapy), bleeding events, concomitant medication reduction, and safety. Sustained response rates reached 48.4% (ELT-to-AVA) and 33.3% (HET-to-AVA), with median response durations of 10 and 7 days respectively. Platelet elevation during AVA treatment was resolved with dosage changes or discontinuation. AVA significantly reduced bleeding, ITP medications, and rescue therapy, with side effects such as gastrointestinal symptoms, headaches, and fatigue (grades 1-2). AVA demonstrates potential as a safe and effective bridging therapy for TPO-RA refractory pediatric ITP, offering hematological stabilization while reducing treatment burden. These findings address current evidence deficiencies in TPO-RA switching protocols.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzoatesDrug SubstitutionHydrazinesPurpura, Thrombocytopenic, IdiopathicPyrazolesReceptors, ThrombopoietinThiazolesAdolescentChildChild, PreschoolFemaleHumansInfantMaleChinaChronic DiseaseCohort StudiesTreatment OutcomeThiophenesEast Asian People

Stichwörter der Autor:innen

AvatrombopagEltrombopagHetrombopagImmune thrombocytopeniaThrombopoietin receptor agonists

Substanzen

avatrombopagBenzoateseltrombopagHydrazinesPyrazolesReceptors, ThrombopoietinThiazolesThiophenes

Autor:innen und Institutionen

  • Hemophilia Comprehensive Care Center, Hematology Department, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, No.56, Nanlishi Road, West District, Beijing, 100045, China.
  • Department of Pediatric, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
  • Department of Pharmacy, Beijing Children's Hospital, Capital Medical University, No. 56, Nanlishi Road, West District, Beijing, 100045, China.
  • Hematology department, Henan Province Children's Hospital, Zhengzhou, 450000, China.
  • Hematology Department, Baoding Children's Hospital, Baoding, 071052, China.
  • Hematologic Disease Laboratory, Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology; National Key Discipline of Pediatrics (Capital Medical University); Key Laboratory of Major Diseases in Childre…

Zitieren

APA

Liu, J., Wang, Z., Wang, N., Ma, J., Wang, L., Liu, Y., Meng, J., Dong, S., Hu, Y., Ouyang, J., Chen, Z., Cheng, X., & Wu, R. (2025). Multicenter, real-world observational study of AVA therapy following ELT/HET switching in Chinese children with persistent/chronic primary ITP. Annals of Hematology. https://doi.org/10.1007/s00277-025-06567-9

Vancouver

Liu J, Wang Z, Wang N, Ma J, Wang L, Liu Y, et al. Multicenter, real-world observational study of AVA therapy following ELT/HET switching in Chinese children with persistent/chronic primary ITP. Annals of Hematology. 2025. doi:10.1007/s00277-025-06567-9

BibTeX
@article{Liu2025,
  author = {Liu, Jingjing and Wang, Zhifa and Wang, Nan and Ma, Jingyao and Wang, Lijuan and Liu, Yan and Meng, Jinxi and Dong, Shuyue and Hu, Yu and Ouyang, Juntao and Chen, Zhenping and Cheng, Xiaoling and Wu, Runhui},
  title = {Multicenter, real-world observational study of AVA therapy following ELT/HET switching in Chinese children with persistent/chronic primary ITP},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06567-9}
}
Kostenlos starten →